Gillian Mitchell
Peter MacCallum Cancer Centre(AU)
Publications by Year
Research Areas
BRCA gene mutations in cancer, Ovarian cancer diagnosis and treatment, Cancer Genomics and Diagnostics, Genetic factors in colorectal cancer, PARP inhibition in cancer therapy
Most-Cited Works
- → Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation(2014)1,667 cited
- → Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial(2010)1,629 cited
- → BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group(2012)1,162 cited
- → Association of Type and Location ofBRCA1andBRCA2Mutations With Risk of Breast and Ovarian Cancer(2015)494 cited
- → Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer(2015)434 cited
- → Efficacy and safety of olaparib monotherapy in germline BRCA1 / 2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy(2015)298 cited